ASRM 2019: Elagolix Plus Add-Back Therapy Reduces Adenomyosis-Related Heavy Menstrual Bleeding
Benefits confirmed for women with adenomyosis and co-existing uterine fibroids in subset analysis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.